Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,506,400 | $1,995,800 | $3,090,200 | $2,488,200 |
| Short-Term Investments | $5,937,200 | $5,473,800 | $5,259,200 | $6,524,300 |
| Receivables | $5,687,100 | $5,610,000 | $5,561,000 | $6,211,900 |
| Inventory | $3,254,400 | $3,205,600 | $3,192,400 | $3,087,300 |
| Other Curr. Assets | $595,600 | $574,300 | $468,900 | $349,200 |
| Total Curr. Assets | $17,980,700 | $16,859,500 | $17,571,700 | $18,660,900 |
| Property Plant & Equip (Net) | $5,002,300 | $4,840,700 | $4,694,200 | $4,599,700 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,380,900 | $1,351,700 | $1,167,000 | $1,148,600 |
| Long-Term Investments | $10,285,700 | $10,058,200 | $9,276,300 | $8,900,100 |
| Tax Assets | $3,846,700 | $3,572,200 | $3,442,900 | $3,314,100 |
| Other NC Assets | $1,673,100 | $1,536,900 | $1,393,100 | $1,136,000 |
| Total NC Assets | $22,188,700 | $21,359,700 | $19,973,500 | $19,098,500 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40,169,400 | $38,219,200 | $37,545,200 | $37,759,400 |
| Liabilities | – | – | – | – |
| Payables | $903,800 | $723,900 | $705,500 | $789,500 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $213,200 |
| Deferred Revenue | $545,600 | $481,900 | $619,300 | $627,700 |
| Other Curr. Liab. | $2,975,700 | $0 | $0 | $0 |
| Total Curr. Liab. | $4,425,100 | $3,667,000 | $3,566,600 | $3,944,300 |
| LT Debt | $1,985,500 | $1,985,100 | $1,984,800 | $1,984,400 |
| Deferred Rev, NC | $219,200 | $206,300 | $211,800 | $185,700 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1,861,800 | $1,701,900 | $1,674,400 | $1,571,400 |
| Total NC Liab. | $4,786,500 | $4,613,300 | $4,591,000 | $4,461,500 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $720,000 | $720,000 | $720,000 | $720,000 |
| Total Liabilities | $9,211,600 | $8,280,300 | $8,157,600 | $8,405,800 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $100 | $100 | $100 | $100 |
| Retained Earnings | $35,045,800 | $33,680,200 | $32,384,400 | $31,672,900 |
| AOCI | $69,000 | $52,500 | $29,100 | -$7,900 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $30,957,800 | $29,938,900 | $29,387,600 | $29,353,600 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $40,169,400 | $38,219,200 | $37,545,200 | $37,759,400 |
| Net Debt | -$520,900 | -$10,700 | -$1,105,400 | -$503,800 |